BG108036A - Нови алкил-фенилимино-имидазолидинови производни за лечение на инконтиненция - Google Patents

Нови алкил-фенилимино-имидазолидинови производни за лечение на инконтиненция Download PDF

Info

Publication number
BG108036A
BG108036A BG108036A BG10803603A BG108036A BG 108036 A BG108036 A BG 108036A BG 108036 A BG108036 A BG 108036A BG 10803603 A BG10803603 A BG 10803603A BG 108036 A BG108036 A BG 108036A
Authority
BG
Bulgaria
Prior art keywords
phen
iminoimidazolidine
isopropyl
tert
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BG108036A
Other languages
Bulgarian (bg)
English (en)
Inventor
Matthias Hoffmann
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BG108036A publication Critical patent/BG108036A/bg
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG108036A 2001-02-10 2003-07-28 Нови алкил-фенилимино-имидазолидинови производни за лечение на инконтиненция Pending BG108036A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz

Publications (1)

Publication Number Publication Date
BG108036A true BG108036A (bg) 2004-12-30

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108036A Pending BG108036A (bg) 2001-02-10 2003-07-28 Нови алкил-фенилимино-имидазолидинови производни за лечение на инконтиненция

Country Status (21)

Country Link
EP (1) EP1362038A1 (hu)
JP (1) JP2004517963A (hu)
KR (1) KR20030076653A (hu)
CN (1) CN1491216A (hu)
AR (1) AR035226A1 (hu)
BG (1) BG108036A (hu)
BR (1) BR0206949A (hu)
CA (1) CA2437809A1 (hu)
CZ (1) CZ20032146A3 (hu)
DE (1) DE10106214A1 (hu)
EA (1) EA200300835A1 (hu)
EC (1) ECSP034700A (hu)
EE (1) EE200300379A (hu)
HU (1) HUP0303004A3 (hu)
IL (1) IL157297A0 (hu)
MX (1) MXPA03007127A (hu)
NO (1) NO20033368D0 (hu)
PL (1) PL362149A1 (hu)
SK (1) SK10132003A3 (hu)
WO (1) WO2002064570A1 (hu)
ZA (1) ZA200305609B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100378097C (zh) * 2003-05-09 2008-04-02 弗·哈夫曼-拉罗切有限公司 作为α-1肾上腺素能激动剂的甲基吲哚和甲基吡咯并吡啶
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
CA2437809A1 (en) 2002-08-22
WO2002064570A1 (de) 2002-08-22
EP1362038A1 (de) 2003-11-19
SK10132003A3 (sk) 2004-02-03
AR035226A1 (es) 2004-05-05
MXPA03007127A (es) 2003-11-18
HUP0303004A3 (en) 2004-07-28
CN1491216A (zh) 2004-04-21
NO20033368L (no) 2003-07-28
NO20033368D0 (no) 2003-07-28
EE200300379A (et) 2003-12-15
EA200300835A1 (ru) 2004-02-26
KR20030076653A (ko) 2003-09-26
DE10106214A1 (de) 2002-08-14
JP2004517963A (ja) 2004-06-17
HUP0303004A2 (hu) 2003-12-29
ECSP034700A (es) 2003-08-29
CZ20032146A3 (cs) 2003-12-17
BR0206949A (pt) 2004-02-25
IL157297A0 (en) 2004-02-19
PL362149A1 (en) 2004-10-18
ZA200305609B (en) 2004-04-29

Similar Documents

Publication Publication Date Title
US4532331A (en) 1-Benzyl-2-aminomethyl imidazole derivatives
WO1997020823A2 (en) 2-amino quinazoline derivatives as npy receptor antagonists
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
CA2563466A1 (en) Anti-cytokine heterocyclic compounds
CA2696429A1 (en) Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
PL128368B1 (en) Process for preparing derivative of imidazoline
JP6814794B2 (ja) Blt阻害活性を有する新規化合物およびこれを有効成分として含む炎症性疾患の予防または治療用組成物
BG108036A (bg) Нови алкил-фенилимино-имидазолидинови производни за лечение на инконтиненция
NO864337L (no) Dopamin-b-hydroksybeta-hydroksylase- inhibitorer.
US4935438A (en) Dopamine-β-hydroxylase inhibitors
JP2006503033A (ja) ベンズイミダゾロン及びサイトカイン抑制剤としてのそれらの使用
AU2005290013A1 (en) Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
GB2272899A (en) Angiotensin-11 receptor blocking cycloalkylbenzylimidazoles
US20020169193A1 (en) Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
US4992459A (en) Dopamine-β-hydroxylase inhibitors
US6602897B2 (en) m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
US6683200B2 (en) N-substituted-N′-substituted urea derivatives and pharmaceutical compositions containing the derivatives
MXPA03003162A (es) Nuevos derivados de m-amino-fenil-imidazolidina para el tratamiento de la incontinencia de orina.
EP2319511A2 (en) Selective subtype alpha 2 adrenergic agents and methods for use thereof
US4772723A (en) Dopamine β-hydroxylase inhibitors
US4863944A (en) Dopamine-β-hydroxylase inhibitors
JPH07101941A (ja) 2−[2−(置換アミノ)ベンジルチオ]−5,6, 7,8−テトラヒドロ−4(3h)−キナゾリノン誘 導体
JP3529112B2 (ja) 2−[2−(置換アミノ)ベンジルチオ]−5,6,7,8−テトラヒドロピリド[4,3−d]ピリミジン−4(3H)−オン誘導体
US4873357A (en) Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors
DK153839B (da) Fremgangsmaade til fremstilling af 5-((1-hydroxy-1-metyl)-aetyl)-1-metyl-2-nitroimidazol